537 related articles for article (PubMed ID: 28281738)
21. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
22. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
24. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
26. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
27. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
28. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
[TBL] [Abstract][Full Text] [Related]
29. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
Shemirani H; Pourrmoghaddas M
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
[TBL] [Abstract][Full Text] [Related]
31. Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial.
Bell RM; Rear R; Cunningham J; Dawnay A; Yellon DM
Clin Res Cardiol; 2014 Mar; 103(3):203-9. PubMed ID: 24292557
[TBL] [Abstract][Full Text] [Related]
32. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
33. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
[TBL] [Abstract][Full Text] [Related]
34. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
35. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
Azzalini L; Spagnoli V; Ly HQ
Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
[TBL] [Abstract][Full Text] [Related]
36. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
37. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
Trials; 2009 Jun; 10():45. PubMed ID: 19563648
[TBL] [Abstract][Full Text] [Related]
39. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
[TBL] [Abstract][Full Text] [Related]
40. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
